Studies related to Bone Fracture Risk and Vitamin K

Vitamin K2 (menatetrenone) Effectively Prevents Fractures And Sustains Lumbar Bone Mineral Density In Osteoporosis

Effect Decrease
Trial Design Cohort
Trial Length 6+ Months
Number of Subjects 241
Sex Both Genders
Age Range 65+
Body Types Average
Notes for this study:
45mg of MK-4 daily for 2 years in persons with osteoporosis is able to reduce both the fracture rate as well as prevent the losses of bone mineral density in the spinal region relative to placebo. There was a trend to increase bone mineral density after the 2 year period, but this failed to reach statistical significance and was small in magnitude.

Full details on all 2 studies are available to Examine memberstry free for 7-days.

Already a member? Login now to access.